Insider · CIK 0001936604

Androski Lindsay

Reports to the SEC for 2 companies · WARMINSTER, PA

sec.gov

Transactions

Companies

Filings

CIK

0001936604

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	ABUSArbutus Biopharma CorpD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−24.7K sh	$5.00	−$123K	47,682
2026-09-18	ABUSArbutus Biopharma CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+116K sh	$3.20	+$373K	144,408
2026-09-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.5K sh	—	—	61,244
2026-09-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−116K sh	—	—	194,014
2026-09-18	ABUSArbutus Biopharma CorpF Tax Payment	Director, President and CEO	FTax Payment	−82.5K sh	$5.07	−$418K	72,337
2026-09-18	ABUSArbutus Biopharma CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.5K sh	$4.39	+$45.9K	154,864
2026-02-02	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+71.7K sh	—	—	71,700
2026-02-02	ABUSArbutus Biopharma CorpA Award	Director, President and CEO	AAward	+28K sh	—	—	28,000
2025-03-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+310K sh	—	—	310,422
2025-01-24	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	—	—	15,750
2025-01-24	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	3,750
2024-10-16	ELOXEloxx Pharmaceuticals, Inc.A Award	Director	AAward	+12K sh	—	—	12,000
2024-01-24	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+7,500 sh	—	—	7,500
2023-01-30	ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+2,859 sh	—	—	2,859
2022-07-01	ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Oct 7 16:094
Androski Lindsay0001447028-26-000058
SEC(opens sec.gov)
Sep 234
Androski Lindsay0001447028-26-000053
SEC(opens sec.gov)
Feb 24
Androski Lindsay0001447028-26-000008
SEC(opens sec.gov)
Mar 204
Androski Lindsay0001447028-25-000072
SEC(opens sec.gov)
Jan 284
Androski Lindsay0001104659-25-006782
SEC(opens sec.gov)
Oct 174
Androski Lindsay0001104659-24-109524
SEC(opens sec.gov)
Jan 264
Androski Lindsay0001104659-24-007291
SEC(opens sec.gov)
Jan 314
Androski Lindsay0001104659-23-008597
SEC(opens sec.gov)
Jul 64
Androski Lindsay0001104659-22-077837
SEC(opens sec.gov)

Companies

Address

C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE

WARMINSTER, PA, 18974